Radiotherapy in the management of synchronous metastatic lung cancer.
Fiche publication
Date publication
août 2023
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine, Dr MARTIN Etienne
Tous les auteurs :
Khalifa J, Lévy A, Sauvage LM, Thureau S, Darréon J, Le Péchoux C, Lerouge D, Pourel N, Antoni D, Blais E, Martin É, Marguerit A, Giraud P, Riet FG
Lien Pubmed
Résumé
Metastatic lung cancer classically portends a poor prognosis. The management of metastatic lung cancer has dramatically changed with the emergence of immune checkpoint inhibitors, targeted therapy and due to a better understanding of the oligometastatic process. In metastatic lung cancers, radiation therapy which was only used with palliative intent for decades, represents today a promising way to treat primary and oligometastatic sites with a curative intent. Herein we present through a literature review the role of radiotherapy in the management of synchronous metastatic lung cancers.
Mots clés
Cancer bronchique non à petites cellules, Cancer bronchique à petites cellules, Maladie oligométastatique, Non-small cell lung cancer, Oligometastatic disease, Radiotherapy, Radiothérapie, Small-cell lung cancer, Synchrone, Synchronous
Référence
Cancer Radiother. 2023 08 11;: